INTRODUCTION
Histiotypic neoplasia in Osteosarcoma (OS) is one of the most common malignant primary bone tumor specifically in the bones of fore limb, hind limb and metaphysical region of long bones (Longhi et al., 2006; Vigorita, 2008) . Damage to the interconnecting soft tissues is a major concern with such kind of tumors (Vigorita, 2008) . It is one of the highly metastasized cellular tumors with pleomorphic spindleshaped cells. These spindle shaped cells are involved in the efficient generation of an osteoid, osteoclast and osteoblast matrix and very well histologically characterize the OS (Vigorita, 2008) . It is reported to have high incidence in adolescents and young ones. 60-70% of survival rate up to five years after diagnosis has been reported in the patients with 8.9% mortality in children (Longhi et al., 2006) . OS is reported to have moderate morbidity (10 to 26 cases/ million/year) (Stiller, 2007) . The metastasized cells most often spread to the lungs, bones and brain (Longhi et al., 2006) . The multi-agent approach involves chemotherapy, surgery and radiation but it is not fully adequate to eliminate OS (ACS, 2013) . Longhi et al. (2006) and NIH (2014) reported, prototype OS manifests few frequent traits like growth rate, cell division with aggression and early pulmonary metastases. Furthermore, Karlsson et al. (2013) reported 33 high inheritable loci for OS in multiple dog breed by genome-wide association study (GWAS) .
Collectively, these data show the dire need of an essential innovative drugs and approaches to further improve the prognosis of OS patients.
Bio-signal trafficking is the pivotal functional mechanism acquired in the differentiation, proliferation, growth and survival of the cells (Lin & Liu, 2008) . During histeotypic neoplasia normal cells follow altered ways to proliferate independently due to growth promoting conditions (Iliopoulos et al., 2009) . At the same time, growth inhibitory signals with respect to metastasis, elicit an angiogenic responses as well as to evade mechanism that arrest cell growth cycle and proliferation (Martin, 2003) . Inhibition of kappa B kinase blocks the induction of nuclear factor-kappaB (NF-κB) signaling and makes bridge between inflammation and cancer (Lin & Liu, 2008; Oeckinghaus et al., 2011) . Ghosh & Karin, (2002) reported regulation of the wide variety of genes encoding cytokines (e.g., IL-1, IL-2, IL-6, IL-12, TNF-α, LTα, LTβ and GM-CSF), chemokines (e.g., IL-8, MIP-1α, MCP1, RANTES and eotaxin), adhesion molecules (e.g., ICAM, VCAM and E-selectin) acute phase proteins (e.g., SAA) and inducible effector enzymes (e.g., iNOS and COX-2) by NF-κB. Moreover, consequently NF-κB-dependent transcription is not only tightly controlled by positive and negative regulatory mechanisms but also closely coordinated with other signaling pathways such as JNK, Akt and MAPK (Baker et al., 2011; Oeckinghaus et al., 2011) .
Small non-coding microRNA (miRNA) is a primary regulator of signal trafficking processes which modulate bio-physiological activities such as developmental timing, proliferation, cell metabolism, differentiation and cell apoptotic activity (Mendell & Olson, 2012) . The modulation takes place by the suppression of several candidate genes during transcription and post-translation on the basis of ambiance. The abnormal expression of miRNA observed in number of cancer patients presents miRNA as candidates targets for the therapeutic intervention of neoplasm including OS (Mitchell et al., 2008; Davis & Hata, 2009) (Ouyang et al., 2013) . Furthermore, the miRNA based approaches for eradication and diagnosis of OS can be handled in two strategic ways (Kobayashi et al., 2012) i.e.
to inhibit the expression of oncogenic miRNA using antisense oligonucleotides (anti-miR) and secondly to induce the expression level of tumor suppressor miRNAs by inserting miRNA mimics (Esquela-Kerscher & Slack, 2006; Shimada, 2013) . A noble approach of study has revealed by Poos et al. (2013) that miRNAs and transcription factors (TFs) are master regulators of the biological systems. In contrast, miRNAs and TFs together make mega diverse network to have desired action and finally results in distinct cellular phenotype. It is reported here that several genes, TFs, and miRNAs form co-regulatory network in OS cell growth as one hallmark in cancer (Poos et al., 2013) . Therefore, at this point the understanding of the role and mode of action of miRNAs is need of hour.
In this study, an attempt has been made to correlate several miRNAs with different factors of nuclear factor of kappa B (NF-κB). A novel bridge model between "miRNAs and NF-κB" has been proposed in the current study to have an efficient control of the OS. The miRNA profiling of primary tumors has prognostic value for the survival rate and it targets the beneficiary results for OS patients who previously had third to sixth-line treatment with antiepidermal growth factor receptor (EGFR) based therapy.
NF-κB VERSUS THE IΚB FAMILY AS MASTER REGULATOR
NF-κB plays a central role in the regulation of diverse biological processes, including immune responses, development, cell proliferation and survival (Esquela-Kerscher & Slack, 2006; Perkins, 2007) . At the same time deregulated NF-κB has been linked to a variety of human diseases; in particular cancers (Perkins, 2007; Karin, 2009 ). The NF-κB, a transcriptional regulator consists of reticuloendotheliosis (Rel) protein dimers and binds with a DNA sequence motif known as κB site (Huxford & Ghosh, 2009 ). Depending upon their requirement for proteolytic processing the Rel protein family is classified into two groups (Huxford & Ghosh, 2009) . The Rel proteins which require proteolytic processing includes NF-κB1 (also known as p105) and NF-κB2 (p100), which are processed to produce the mature p50 and p52 proteins, respectively (Fig. 1) . The Rel protein without proteolytic processing includes Rel A (also known as p65), Rel-B and Rel-C. NF-κB signal cascade involves canonical and non-canonical pathways (Sun, 2011) .
It is worth mentioning over here that canonical pathway induced by extracellular factors includes tumor necrosis factor α (TNF-α) and Interlukin-1 (IL-1) those activate NF-kappa-B essential modulator (NEMO) (Oeckinghaus et al., 2011) . Further it has been reported that NEMO makes complex with Inhibitor kappa kinase (IKK) α/β and p50/ RelA to phosphorylate the Inhibitor of kappa B alpha (IkBα). Later, phosphorylated p50/RelA translocates to nucleous to activate target genes (Ghosh & Karin, 2002) .
Similarly, Lipopolysacharide (LPS) and CD40L are reported to activate NF-inducing kinase (NIK) to initiate noncanonical pathway by involving IKKα/β, p100, RelB complex and phosphorylated p100 activate RelB/p52 (Sun, 2011 ) which translocate to nucleous and interact with target κB element and regulate transcription (Lin et al., 1998 All known NF-κB activators converge toward the IKK complex to activate the canonical and non-canonical NF-κB pathways (Sun, 2011) . The IKK complex contains two catalytic (IKKα and IKKβ) and a regulatory subunit (NEMO/IKKγ) which those regulate the canonical NF-κB pathway, whereas IKKα regulates the non-canonical pathway (Oeckinghaus et al., 2011) . The process of IKKα activation and its role in the regulation of canonical NF-κB activation remain elusive (Hoesel & Schmid, 2013 (Rieser et al., 2013) . Furthermore, NF-κB can be downregulated by cysteine methylation mediated disruption of Ubiquitin chain via E. coli NIeE, S-adenosyl-L-methionine-dependent methyltransferase activity in the the Npl4 zinc finger (NZF) domains in TAB2 and TAB3 . The to TNF receptor-associated factor 2/Receptor-interacting serine/threonine-protein kinase 1 (TRAF2/RIP1) (Solt et al., 2007) . It further triggers a series of events involving signaling cascade ( those inhibit NF-κB activity is generated in neurons undergoing apoptosis (Mattson & Camandola, 2001) . NF-κB is modulated by signals ( Fig. 2 ) emanated from activator protein-1(AP1), glucose-regulated protein-78 (GRP-78), Jun NH 2 -terminal kinase (JUNK), cyclic guanosine monophosphate (cGMP)-dependent protein kinases (PKGs) and cGMPdependent protein kinase (Mattson & Camandola, 2001 ).
Moreover, TLR2/4, TNF, IL-6, IL-1 and endoplasmic reticulum (ER) stress during metabolic imbalance show insulin resistance which later activate cytokine inflammatory as well as insulin regulating trafficking by Toll-like and cytokine receptors through MyD88 (Baker et al., 2011) . In addition the death domain adaptor molecules via TRAFs result in phosphorylation and activation of the IKK complex which control the diabetogenesis (Fig. 2) (Chen, 2005) . It leads to activated macrophage production, inflammatory action that cause adipocyte death, suppression of Insulin receptor substrate 1/2 (IRS-1/2), inhibition the leptin and negatively control the obesity (Baker et al., 2011) . In early stages of tumorigenesis or viral infection, the cytoprotective effect of NF-κB is beneficial because it prevents hepatocyte cell death, and thus avoiding the release of IL-1a by necrotic hepatocytes and the triggering of compensatory proliferation (Sun & Karin, 2008) . allowing them to proliferate (Sakuda et al., 2002) . In addition (Fig. 2) to oxidative stress, the excessive hepatocyte death in both IKKβ knockouts and IKKγ knockouts is because of prolonged activation of JNK (Sakurai et al., 2006; Sun & Karin, 2008) . NF-κB is crucial for innate immune defense against microbial infection (Hayden & Ghosh, 2008; Vallabhapurapu & Karin, 2009 Conclusively, the roles played by NF-κB (Fig. 2) in autoimmunity, drugs which target it and complexities which need to be addressed to improve the use of NF-κB as a target has been described (O'Sullivan et al., 2007; Uwe, 2008) . These facts support its master regulator activity.
The immune system has evolved a variety of receptors to recognize invading microorganisms (pathogens, bacteria and viruses) which result activation of NF-κB trafficking by gene regulation reported by Rahman et al. (2011) . In contrast, (Fig. 2) immune regulation by secreted pathogen derived proteins (NS3, gp350, Core) and viral coded proteins can induce TLR, TNFR and other receptors to activate MyDD88 and TAK1 (Rahman et al., 2011) . It also upregulate the IκBα and control the NF-κB.
ROLE OF miRNAs AS NOVEL CLINICAL BIOLOGICAL PLAYERS IN OS
miRNAs play as mega diverse roles as tumor suppressors, oncogenes inducers or both in some cases (Davis & Hata, 2009 ). These qualities of miRNAs keep them as essential multipurpose prognostic and diagnostic tools in various oncogenesis including OS (Kobayashi et al., 2012) . Normally miRNAs are present in various parts of the body in the form of fluids as serum, plasma, saliva, urine and milk (Chen et al., 2008; Mitchell et al., 2008; Zhou et al., 2013) .
Abnormal levels of miRNA can cause and are tightly linked with cancers and diseases including OS (Chen et al., 2008; Mitchell et al., 2008; Zhou et al., 2013) . Studies have demonstrated diverse genetic alterations in OS cells including structural abnormalities, gain and/or loss of chromosomes, mutation in tumor suppressor genes and epigenetic modifications (Kansara & Thomas, 2007; Broadhead et al., 2011) . OS is characterized by a high propensity for pulmonary metastasis. Novel therapeutic targets and approaches are required to suppress pulmonary metastasis of OS and improve prognosis which is a major cause of death (Longhi et al., 2006) . NF-κB can induce the synthesis of proteins that regulate miRNAs (Hoesel & Schmid, 2013 Furthermore, p53 dissociate from p53-specific E2 Ubiquitin protein ligase and is reported to arrest cell cycle and apoptosis to repair/damage cells (Kobayashi et al., 2012) .
The most important so far example is of NF-κB-dependent induction of Lin28, a protein which inhibits the processing and maturation of let-7 miRNAs. Further, members of let-7 miRNA family are often down-regulated in cancer and which seems to act as tumor suppressor (Fig. 1) revealed that up-regulation of GSK-3β activity is directly and jointly involved in tumor progression and clonogenicity . Further it has been reported that cell survival in OS in which induction of blocking of GSK-3β
down-regulates the function of NF-κB pathway genes and act as anti-tumorigenic through in-vitro and mouse models (Tang et al., 2012) . Therefore, therapeutic targeting of GSK-3β mediated inhibition of NF-κB pathway could be novel strategy to overcome against OS in-vitro and in-vivo.
Reports by Silverman & Maniatis (2001) 
IMPORTANT SUPPRESSOR miRNAs IN OS
There are several mRNAs which can ameliorate tumor progression and metastasis by gene silencing or other ways and mechanisms (Mendell & Olson, 2012) Geng et al. (2014) and ERK5) to regulate post transcription in OS and cancer development (Table 1) . Duan et al. (2011) studied, miR199a-3p, miR-127-3p influence the mTOR, STAT3 that arrest cell cycle (Table 1) . Next, He et al. (2009) and Wu et al. (2013) showed, miR-34 family jointly with CDK6, Cyclin E2, Bcl2 possess p53 dependent apoptosis in OS (Table 1) . Thayanithy et al. (2012) , reported that miRNAs (miR-382, miR-134, miR-369 and miR-544) arrest cell cycle and apoptosis via down-regulating the expression of c-Myc in OS (Table 1) . 3'UTR silenced of VEGF by miR-145 in OS ( Table 1 ) that control the tumor progression (Fan et al., 2012) . The miR-218 causes lesion the OS by targeting of TIAM1, MMP-2 and MMP-9 (Table 1) (Table 1) .
NEOPLASIA PROMOTER miRNAs IN OS
OS are complex bone tumors with various genomic alterations (Smida et al., 2010) . Polygenic spectrum of germline risk factors pointing towards specific pathways as drivers of disease; it implicates 33 inherited risk loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B (Karlsson et al., 2013) . These alterations affect the expression and function of several genes by overexpressed miRNAs in OS patients (Namløs et al., 2012) . Genomic alterations are also associated with several transcription factor (TF), co-regulate networks in OS cell proliferation (Poos et al., 2013) . Some clinically candidate miRNAs (miR-196a and miR-196b) have been demonstrated to play a crucial role in normal cell differentiation, proliferation and in tumorgenesis of various cancer types (Table   1) including OS cell lines relative to normal bone (Namløs et al., 2012; Zhang et al., 2014) . Another miR-33a is up-regulated in chemoresistant OS (Fig. 1) .
The level of miR-33a is negatively correlated with the TWIST protein level and the tumor necrosis rate in OS . In addition, miR-33a promotes OS cell resistance to cisplatin by down-regulating TWIST. Actually, TWIST is a pivotal negative regulator of OS chemoresistance (Table 2) . Several miRNAs are key of modulator specifically, 14q32 miRNAs are up-regulated upon osteoblast maturation while overexpression (Exogenous) of 14q32 miRNAs leads to reduction in cMYC protein by blocking miR-17-92 or cMYC depletion which induces apoptosis in OS (Thayanithy et al., 2012; Shimada, 2013) . Invasiveness induced through miR-362 by induced nuclear translocation of p65 and inversely regulates the CYLD expression by binding its 3′untranslated region in Gastric cancer (Fig. 1) including OS (Xia et al., 2014) . Dysfunctional NF-κB activity contributes to various human conditions, including autoimmune, inflammatory disorders and cancer by miR125a and miR-125b (Kim et al., 2012; Tan et al., 2012) . It directly Inhibit tumor necrosis factor alpha-induced protein 3 (TNFAIP3) expression, down-regulate the p38α via UV that elevates NF-κB Activity in diffuse large B-cell lymphoma (DLBCL) and OS (Fig. 1) . Won et al. (2013) showed, the expression of 10 miRNAs (HS-169, HS-29, miR-10b, miR-150, miR-199b-5p, miR-223, miR-338-3p, miR-451, miR891a and solexa-578-1915) has been reported to increase 10-fold in OS as compared with normal controls by microarray analysis (Table 2) . Ziyan et al. (2011) reported, potential regulation of RECK by miR-21; it is over expressed in OS.
A BRIDGING AVENUE TO AMELIORATE ONCOGENESIS THROUGH miRNAs AND NF-κB
The nuclear factor-KappaB (NF-κB) pathway is conserved from fruit flies to humans and is a key mediator of in-flammatory signaling (Minakhina & Steward, 2006; OlarerinGeorge et al., 2013) . Aberrant regulation of NF-κB is reported to be associated with autoimmune diseases, chronic inflammation and cancers (Silverman & Maniatis, 2001) . It makes the NF-κB pathway an attractive therapeutic target (Olarerin-George et al., 2013) . NF-κB is a transcriptional regulator consisting of reticuloendotheliosis (Rel) protein dimers that bind a DNA sequence motif known as κB site (Karin, 2009) . NF-κB activation is a result of underlying inflammation or the consequence of formation of an inflammatory microenvironment during malignant progression (Perkins, 2007; Karin, 2009) . It has ability to up-regulate the expression of tumor promoting cytokines, such as IL-6 or STAT3 and survival genes, such as Bcl-XL (Perkins, 2007; Karin, 2009) . The basic-helix-loop-helix (b-HLH)
factor Twist-1 is reported as a new mediator of the protective function of NF-κB and it blocks PCD induced by chemotherapeutic drugs and TNF-alpha in NF-κB-deficient cells (Pham et al., 2007) . It is also essential to counter this PCD in cancer cells via dephosphorylation of BCl-2. Next, Tan et al. (2012) showed, activation of NF-κB by UV is required for miR-125b induction in colon cancer and OS.
Deregulated miR-143 in cancers including OS directly target BCl2 and anti-apoptotic molecule and regulate NF-κB (Zhang et al., 2010) . While, Chen et al. (2013) demonstrated the miR-16 inhibits the proliferation and metastasis of OS by targeting IGF1R and suppression of Raf-MEK1/2, ERK1/2 in nude mouse (Table 1) . Geng et al. (2014) reported that Rac1 targeted by miR-124 that attenuated the cell proliferation, invasion and metastasis in MG-63 U2OS cell lines. Similarly, miR-26b (Fig. 1 ) inhibited the expression of TAK1 and TAB3 by binding to their 3'-untranslated region in hapatocarcinoma cells (Zhao et al., 2014) . and miR-34 family directly suppress the IL-6, STAT3 and MMP-9 (Table 1) which down-regulate the Rel family subunits and palliate from carcinogenesis (He et al., 2009; Iliopoulos et al., 2009; Zhou et al., 2013) . Although, these miRNAs can regulate not only NF-κB bio-molecular mechanism but also involve in various type of signaling pathways in neoplasia (Davis & Hata, 2009 ). On the other (Kim et al., 2012; Tan et al., 2012; Xia et al., 2014) .
Moreover, miR-33a, overexpression causes drug resistance in OS by targeting TWIST . 
